FindTrial
Sign In

"A study to compare two different route of using Phenylephrine in order to prevent hypotension in pregnant patients"

" Prophylactic use of Intravenous Phenylephrine versus Intranasal Phenylephrine in prevention of spinal induced hypotension in Obstetric Patients - A Comparative Study"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039516
Enrollment
120
Registered
2022-01-18
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: PHENYLEPHRINE: Intravenous route -100 micro gram ,every 15 min interval upto 45 mins and after that,whenever it is required Control Intervention1: PHENYLEPHRINE: Intranasal route - 100

Sponsors

Dr Sankar Roy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients need emergency LUCS 2.Patients of ASA 1 and ASA 2. 3.Age above 39 weeks of gestation 4.Patients with Mallampati grade 1 and 2 5. Who are willing to participate for this study

Exclusion criteria

Exclusion criteria: 1.Eclampsia 2.Antepartum Haemorrhage 3.Foetal distress absolute contraindication to spinal anaesthesia 4.Patient refusal 5.Patient receiving any nasal decongestant within 24hrs prior to surgery 6.Having nasal congestion

Design outcomes

Primary

MeasureTime frame
To compare the effectiveness of Phenylephrine via different route in preventing spinal induced hypotension in emergency LUCSTimepoint: 6 month after approval of ethical committee—

Secondary

MeasureTime frame
To Observe any other side effect of the drug for example - nasal congestion, bradycardiaTimepoint: 6 month after approval of ethical committee—

Countries

India

Contacts

Public ContactDrSankar Roy

RG Kar Medical College and Hospital

dr.sankar.roy2010@gmail.com9434165426

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026